Replies to post #5989 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>The popularity of this notion stems from three facts:
1) GTCB is Genzyme's baby historically...
2) Suitable geographic location...
3) Genzyme is known to be opportunistic in such matters...<

I would add a fourth reason: People like you imagine that they are being astute for “recognizing” the high likelihood of a GENZ takeover in the event that things go well for GTC.

[ThomasS]

I think a better question is: what difference does it make who buys GTC?
Genzyme, Baxter, Novartis, or American Express... what difference does it make?
GENZ would not necessarily get a better price than Caterpillar, for example...

[gym gravity]

and why not change their name?